Figure 3
From: Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
CTCE-9908 intervention studies with PC-3 orthotropic prostate tumors. PC-3 tumors were grown in mouse prostate through orthotropic implantation. 25 mg/kg of CTCE-9908 was administered to the mice. A) Whole body GFP fluorescence image of mice. B) Prostate tumor volume was measured by calipers. C) Total GFP fluorescence of mice.